LEXICON PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
59 Contracts & Agreements
- Indenture Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (12)
- Note Agreements (1)
- Purchase Agreements (15)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Share Agreements (1)
- Stock Agreements (19)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (1)
- Fifth Amendment to Loan and Security Agreement, dated March 6, 2024, with Oxford Finance, LLC and the lenders listed therein (Filed With SEC on March 11, 2024)
- Preferred Stock Purchase Agreement, dated as of March 11, 2024, among Lexicon Pharmaceuticals, Inc. and the purchasers party thereto (Filed With SEC on March 11, 2024)
- Fourth Amendment to Loan and Security Agreement, dated December 29, 2023, with Oxford Finance, LLC and the lenders listed therein (Filed With SEC on December 29, 2023)
- Third Amendment to Loan and Security Agreement, dated June 23, 2023, with Oxford Finance, LLC (Filed With SEC on June 28, 2023)
- Purchase Agreement, dated as of May 31, 2023, among Lexicon Pharmaceuticals, Inc. and Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus... (Filed With SEC on June 2, 2023)
- Underwriting Agreement, dated as of May 31, 2023, by and among Lexicon Pharmaceuticals, Inc. and Citigroup Global Markets Inc., Jefferies LLC and Piper Sandler & Co., as... (Filed With SEC on June 2, 2023)
- Second Amendment to Loan and Security Agreement, date May 1, 2023, with Oxford Finance, LLC (Filed With SEC on May 2, 2023)
- Form of Restricted Stock Unit Agreement (Filed With SEC on March 3, 2023)
- First Amendment to Loan and Security Agreement, dated August 29, 2022, with Oxford Finance, LLC (Filed With SEC on September 2, 2022)
- Purchase Agreement, dated as of July 27, 2022, among Lexicon Pharmaceuticals, Inc. and Invus US Partners LLC (Filed With SEC on July 29, 2022)
- Purchase Agreement, dated as of July 27, 2022, among Lexicon Pharmaceuticals, Inc. and Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus... (Filed With SEC on July 29, 2022)
- Underwriting Agreement, dated as of July 27, 2022, by and among Lexicon Pharmaceuticals, Inc. and Citigroup Global Markets Inc. and Piper Sandler & Co., as representatives of the... (Filed With SEC on July 29, 2022)
- Form of Restricted Stock Unit Agreement with Officers (Filed With SEC on March 10, 2022)
- Description of Common Stock (Filed With SEC on March 10, 2022)
- Description of Common Stock (Filed With SEC on March 12, 2021)
- Subscription Agreement (Filed With SEC on December 11, 2020)
- Real Estate Purchase and Sale Agreement, dated October 16, 2020, between Lex-Gen Woodlands, L.P. and Nurix Therapeutics, Inc (Filed With SEC on October 22, 2020)
- Asset Purchase and Sale Agreement, dated July 29, 2020, by and between Lexicon Pharmaceuticals, Inc. and TerSera Therapeutics LLC (Filed With SEC on September 11, 2020)
- Real Estate Purchase and Sale Agreement, dated July 10, 2020 (Filed With SEC on July 15, 2020)
- Second Amendment to Real Estate Purchase and Sale Agreement (Filed With SEC on April 27, 2020)
- First Amendment to Real Estate Purchase and Sale Agreement (Filed With SEC on April 27, 2020)
- Form of Restricted Stock Unit Agreement with Officers (Filed With SEC on March 12, 2020)
- Real Estate Purchase and Sale Agreement, dated January 10, 2020, between Lex-Gen Woodlands, L.P. and FFC Equity Holdings, L.P (Filed With SEC on January 16, 2020)
- Term Loan and Security Agreement, dated as of August 30, 2018, between Lex-Gen Woodlands, L.P. and Revere Credit Opportunities Fund III, LP (Filed With SEC on September 4, 2018)
- Seventh Amendment to Loan and Security Agreement and to Other Loan Documents, dated April 20, 2018, between Lex-Gen Woodlands, L.P. and iStar Lex Lender LLC (Filed With SEC on April 23, 2018)
- Loan and Security Agreement, dated April 21, 2004, between Lex-Gen Woodlands, L.P. and iStar Financial Inc., as amended (Filed With SEC on March 1, 2018)
- Form of Notice of Stock Option Grant to Directors (Filed With SEC on March 1, 2018)
- Form of Restricted Stock Unit Agreement with Officers (Filed With SEC on March 1, 2018)
- Form of Stock Option Agreement with Officers (Filed With SEC on March 1, 2018)
- Loan Agreement, dated as of December 4, 2017, among Lexicon Pharmaceuticals, Inc., as Borrower, certain subsidiaries of the Borrower, as Guarantors, BioPharma Credit PLC, as... (Filed With SEC on December 5, 2017)
- COMMERCIAL SUPPLY AGREEMENT (Telotristat Etiprate (LX-1606 Hippurate) immediate release compressed powder 250mg tablets (as free base)) (Filed With SEC on May 4, 2017)
- SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT AND TO OTHER LOAN DOCUMENTS (Filed With SEC on April 21, 2017)
- RESTRICTED STOCK UNIT AGREEMENT (Officer Restricted Stock Unit) (Filed With SEC on March 6, 2017)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED PURCHASE OPTION AGREEMENT (Filed With SEC on October 5, 2016)
- NOTICE OF STOCK OPTION GRANT (Non-Employee Director Stock Option) (Filed With SEC on March 11, 2016)
- REAL ESTATE PURCHASE AND SALE AGREEMENT BETWEEN LEX-GEN WOODLANDS, L.P. AND TC HOUSTON OFFICE DEVELOPMENT, INC. CONCERNING PROPERTY COMMONLY KNOWN AS 8800 TECHNOLOGY FOREST PLACE... (Filed With SEC on January 22, 2016)
- LEXICON PHARMACEUTICALS, INC. AND WELLS FARGO BANK, NATIONALASSOCIATION, as Trustee INDENTURE Dated as ofNovember 26, 2014 5.25% Convertible Senior Notes due 2021 TABLE OF CONTENTS (Filed With SEC on November 28, 2014)
- PURCHASE AGREEMENT (Filed With SEC on November 21, 2014)
- $80,000,000 LEXICONPHARMACEUTICALS, INC. 5.25% Convertible Notes Due 2021 PURCHASE AGREEMENT (Filed With SEC on November 21, 2014)
- 49,751,244 Shares LEXICON PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on November 21, 2014)